2 completed. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Henrietta Bada: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain Clonidine, Morphine - Neonatal Abstinence Syndrome | Phase 3 | Completed | Henrietta Bada | 120 | 2017-12-07 | 2025-05-23 |
| NAS Treatment - Opiate Versus Non-Opiate Morphine, Clonidine - Neonatal Abstinence Syndrome | Phase 4 | Completed | Henrietta Bada | 31 | 2011-09-01 | 2017-09-12 |
Neonatal Abstinence Syndrome (2) · Chemically-Induced Disorders (1) · Infant, Newborn, Diseases (1) · Mental Disorders (1) · Substance-Related Disorders (1)
United States (2)
Henrietta S Bada, MD (1) · Henrietta S Bada, MD MPH (1)
PMID 25624389, PMID 34231914, PMID 39575611
R01DA043519 (1)